Gilead Sciences Inc.

GILD | NASDAQ

Price Alert Chart Builder DCF Calculator

$150.56

+$0.45 (+0.30%)

At close: Sep 21, 2026, 4:00 PM ET

$149

-$1.56 (-1.04%)

After-hours: Sep 21, 2026, 7:57 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	30.46B	29.73B	29.44B	29.09B	28.86B	28.73B	28.75B	28.3B	27.8B	27.45B	27.12B	27.39B	27.38B	27.04B	27.28B	27.14B	27.52B	27.47B	27.31B	27.48B	26.64B	25.56B
Cost of Revenue	6.22B	6.14B	6.23B	6.19B	6.2B	6.24B	6.25B	6.76B	6.75B	6.65B	6.5B	5.8B	5.63B	5.63B	5.66B	6.89B	6.72B	6.66B	6.6B	5.37B	5.29B	4.96B
Gross Profit	24.24B	23.6B	23.21B	22.9B	22.67B	22.5B	22.5B	21.54B	21.05B	20.8B	20.62B	21.59B	21.75B	21.41B	21.62B	20.25B	20.8B	20.81B	20.7B	22.11B	21.35B	20.6B
Operating Income	-1.49B	11.38B	11.03B	10.49B	8.05B	8.22B	1.66B	822M	2.56B	1.58B	7.61B	8.26B	8.47B	8.84B	7.33B	6B	7.01B	7.23B	9.92B	11.63B	9.79B	4.56B
Interest Income	183M	256M	350M	340M	304M	266M	280M	195M	249M	214M	106M	106M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-1.96B	10.73B	9.8B	9.89B	7.2B	6.83B	690M	176M	1.54B	1.07B	6.86B	7.24B	7.35B	7.27B	5.81B	4.54B	5.55B	5.86B	8.28B	9.33B	6.72B	1.93B
Net Income	-3.24B	9.22B	8.51B	8.11B	6.31B	5.97B	480M	126M	1.05B	484M	5.66B	5.88B	5.48B	5.58B	4.59B	3.33B	4.14B	4.52B	6.23B	7.39B	5.16B	301M
Selling & General & Admin	6.46B	5.9B	5.71B	5.84B	5.89B	5.91B	6.02B	5.74B	5.65B	6.12B	6.06B	6.5B	6.4B	5.91B	5.67B	5.3B	5.28B	5.27B	5.25B	5.33B	5.24B	5.13B
Research & Development	6.07B	5.79B	5.8B	5.86B	5.91B	5.77B	5.91B	5.67B	5.74B	5.79B	5.72B	3.16B	2.85B	2.55B	4.98B	8.16B	8.11B	8.1B	5.28B	4.83B	4.88B	5.09B
Other Expenses	13.21B	526M	673M	707M	2.82B	2.6B	8.91B	9.3B	7.11B	7.31B	1.23B	3.66B	4.02B	4.12B	3.64B	786M	403M	211M	265M	329M	1.44B	5.82B
Operating Expenses	25.73B	12.22B	12.18B	12.41B	14.62B	14.27B	20.84B	20.72B	18.5B	19.22B	13.01B	13.33B	13.27B	12.57B	14.29B	14.25B	13.79B	13.58B	10.79B	10.48B	11.56B	16.04B
Interest Expense	998M	1.01B	1.03B	1.02B	1B	984M	978M	981M	975M	968M	944M	918M	915M	927M	935M	947M	968M	982M	1B	1.03B	1.02B	1B
Selling & Marketing Expenses	2.8B	3.67B	3.52B	3.32B	3.45B	3.4B	3.39B	3.34B	2.37B	1.57B	826M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	31.95B	18.36B	18.42B	18.6B	20.81B	20.51B	27.09B	27.48B	25.25B	25.87B	19.51B	19.13B	18.91B	18.21B	19.95B	21.13B	20.51B	20.25B	17.39B	15.85B	16.85B	21.01B
Income Tax Expense	1.29B	1.51B	1.29B	1.78B	890M	860M	211M	63M	506M	617M	1.25B	1.41B	1.91B	1.73B	1.25B	1.23B	1.44B	1.37B	2.08B	1.96B	1.58B	1.66B
Shares Outstanding (Basic)	1.24B	1.24B	1.24B	1.24B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B
Shares Outstanding (Diluted)	1.24B	1.25B	1.25B	1.25B	1.26B	1.26B	1.26B	1.25B	1.25B	1.25B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B
EPS (Basic)	-2.60	7.42	6.85	6.52	5.06	4.78	0.38	0.10	0.85	0.40	4.55	4.71	4.39	4.46	3.66	2.65	3.28	3.58	4.95	5.89	4.12	0.25
EPS (Diluted)	-2.67	7.34	6.77	6.45	5.02	4.75	0.37	0.09	0.82	0.36	4.50	4.66	4.35	4.43	3.64	2.64	3.27	3.57	4.93	5.86	4.10	0.23
EBITDA	636M	14.02B	13.58B	13.67B	10.97B	10.58B	4.44B	3.92B	5.27B	4.78B	10.5B	10.69B	10.64B	10.41B	8.85B	7.6B	8.62B	8.95B	11.33B	12.31B	9.51B	4.53B
EBIT	-1.43B	11.26B	10.82B	10.91B	8.2B	7.81B	1.67B	1.16B	2.51B	2.04B	7.8B	8.16B	8.27B	8.19B	6.75B	5.49B	6.52B	6.84B	9.28B	10.36B	7.74B	2.93B
Depreciation & Amortization	2.06B	2.75B	2.76B	2.77B	2.77B	2.77B	2.77B	2.76B	2.76B	2.74B	2.69B	2.53B	2.37B	2.22B	2.1B	2.11B	2.11B	2.1B	2.05B	1.94B	1.77B	1.6B